Collagen Vascular Diseases Disease-related Risk of Vertebral Fracture During Glucocorticoid Treatment of SUGIYAMA

نویسندگان

  • NAOKO HASHIMOTO
  • TAKAFUMI MAYAMA
  • TOMOAKI TANAKA
  • ICHIRO TATSUNO
  • SAWAKO SUZUKI
  • TOMOHIKO YOSHIDA
  • HIDEKAZU NAGANO
چکیده

Volume 38, no. 10 Collagen Vascular Diseases Disease-related Risk of Vertebral Fracture During Glucocorticoid Treatment of SUGIYAMA NAOKO HASHIMOTO, TAKAFUMI MAYAMA, TOMOAKI TANAKA and TAKAO ICHIRO TATSUNO, SAWAKO SUZUKI, TOMOHIKO YOSHIDA, HIDEKAZU NAGANO, http://www.jrheum.org/content/38/10/2270 J Rheumatol 2011;38;2270-2272 http://www.jrheum.org/alerts 1. Sign up for TOCs and other alerts http://jrheum.com/faq 2. Information on Subscriptions http://jrheum.com/reprints_permissions 3. Information on permissions/orders of reprints

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Collagen Vascular Diseases Disease - related Risk of Vertebral Fracture During Glucocorticoid Treatment

Volume 38, no. 10 Collagen Vascular Diseases Disease-related Risk of Vertebral Fracture During Glucocorticoid Treatment of SUGIYAMA NAOKO HASHIMOTO, TAKAFUMI MAYAMA, TOMOAKI TANAKA and TAKAO ICHIRO TATSUNO, SAWAKO SUZUKI, TOMOHIKO YOSHIDA, HIDEKAZU NAGANO, http://www.jrheum.org/content/38/10/2270 J Rheumatol 2011;38;2270-2272 http://www.jrheum.org/alerts 1. Sign up for TOCs and other alerts ht...

متن کامل

Very high frequency of fragility fractures associated with high-dose glucocorticoids in postmenopausal women: A retrospective study☆

Purpose To evaluate the incidence of fragility fractures associated with high-dose glucocorticoid therapy in patients with systemic rheumatic disease. METHODS A retrospective study of patients who were treated with high-dose prednisolone (> 0.8 mg/kg) for systemic rheumatic disease at Kobe University Hospital from April 1988 to March 2012. The primary outcome was a major osteoporotic fracture...

متن کامل

Incidence of Symptomatic Vertebral Fractures Among Newly Diagnosed Autoimmune Diseases Initiating Glucocorticoid Therapy

Few data are available regarding vertebral fracture risk in patients treated with corticosteroids including patients with interstitial lung disease (ILD). The aim of the present study was to identify risk factors for symptomatic vertebral fracture analyzed in patients with newly diagnosed autoimmune diseases.This was an observational cohort study conducted in the National Hospital Organization-...

متن کامل

Risk of long-term infection-related death in clinical osteoporotic vertebral fractures: A hospital-based analysis

BACKGROUND Osteoporotic vertebral fractures adversely impact quality of life and also increase the risk of infection and mortality. Alendronate treatment increases bone mass and reduces the risk of fractures in patients with osteoporosis by suppressing bone resorption. We investigated the relationship between alendronate treatment and infection-related death in patients with osteoporotic verteb...

متن کامل

Bisphosphonates and glucocorticoid-induced osteoporosis: cons

During the use of glucocorticoids (GCs), both vertebral and nonvertebral fracture risk are increased, due to the direct and indirect negative effects of GCs on bone, muscles, and the activity of the underlying inflammatory diseases. Inhibition of bone formation and increased apoptosis of osteocytes play a consistent and crucial role in the pathogenesis of glucocorticoid-induced osteoporosis (GI...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2011